Acuvi's core product is built on piezo technology that converts electrical energy into motion in microscopic motors used to steer surgical robots, produce semiconductor chips and enable high‑precision optical instruments. The company manufactures its key components in Uppsala and supplies major customers in semiconductors, diagnostics and robotics. In Q2 2025 Acuvi reported sales of SEK47 million (up from SEK43 million year‑over‑year), a gross margin of 65%, and EBITDA before depreciation rising from SEK8 million to SEK12 million (a 25% margin). Management forecasts full‑year EBITDA of SEK52–55 million (about a 70% increase) and the board has raised long‑term financial targets to a 25–30% EBITDA margin and profits above SEK85 million by 2027. To accelerate growth Acuvi has taken financing actions and is expanding its go‑to‑market footprint. It recently opened a sales office in San Jose and plans market entries in Tokyo and Germany in 2026, while pursuing organic growth and possible acquisitions. The company has also secured large orders, including an automation contract projected to generate SEK100–150 million over coming years.

Total raised

$11M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2025